Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome

Schizophrenia Research

Volumn 153, Issue 1-3, 2014, Pages 231-236

  Monks, Stephen ^b   Niarchou, Maria ^a   Davies, Aimée R ^a   Walters, James T R ^a   Williams, Nigel ^a   Owen, Michael J ^a   Van den Bree, Marianne B M ^a   Murphy, Kieran C ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b BEAUMONT HOSPITAL   (Ireland)

Author keywords

22q11.2DS; COMT; Schizophrenia; Schizotypy

Indexed keywords

CATECHOL METHYLTRANSFERASE; COMT PROTEIN, HUMAN;

22Q11.2 DELETION SYNDROME; ADOLESCENT; ADULT; ARTICLE; CHROMOSOME DELETION 22Q11; COMPARATIVE STUDY; COMT GENE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENETIC ANALYSIS; GENOTYPE; GLOBAL ASSESSMENT OF FUNCTIONING; HAPLOTYPE; HUMAN; INCIDENCE; INTELLIGENCE QUOTIENT; KINGS SCHIZOTYPY QUESTIONNAIRE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OXFORD LIVERPOOL INVENTORY OF FEELINGS AND EMOTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHEDULES FOR CLINICAL ASSESSMENT IN NEUROPSYCHIATRY; SCHEDULES FOR THE ASSESSMENT OF POSITIVE AND NEGATIVE SYMPTOM; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; SYMPTOM ASSESSMENT; COMPLICATION; DIGEORGE SYNDROME; GENETIC ASSOCIATION; GENETICS; INTELLIGENCE; MIDDLE AGED; NONPARAMETRIC TEST; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM; YOUNG ADULT;

ADOLESCENT; ADULT; CATECHOL O-METHYLTRANSFERASE; DIGEORGE SYNDROME; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; GREAT BRITAIN; HUMANS; INTELLIGENCE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84895789782     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.01.020     Document Type: Article

References (45)

1. Allen N.C., Bagade S., McQueen M.B., Ioannidis J.P., Kavvoura F.K., Khoury M.J., et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. [Meta-Analysis Research Support, Non-U.S. Gov't]. Nat. Genet. 2008, 40(7):827-834.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Press, Washington, DC. 4th ed.
3. Ammons R., Ammons C.H. The Quick Test (QT): Provisional Manual. Psychol Rep 1962, 11(1):111-161.
4. Scale for the Assessment of Negative Symptoms in Schizophrenia 1982, University of Iowa, Iowa City. N.C. Andreasen (Ed.).
5. Scale for the Assessment of Positive Symptoms (SAPS) 1983, University of Iowa, Iowa City. N.C. Andreasen (Ed.).
6. Baker K.D., Skuse D.H. Adolescents and young adults with 22q11 deletion syndrome: psychopathology in an at-risk group. Br. J. Psychiatry 2005, 186:115-120.
7. Barnett J.H., Jones P.B., Robbins T.W., Muller U. Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls. Mol. Psychiatry 2007, 12(5):502-509.
8. Bassett A.S., Chow E.W., AbdelMalik P., Gheorghiu M., Husted J., Weksberg R. The schizophrenia phenotype in 22q11 deletion syndrome. Am. J. Psychiatry 2003, 160(9):1580-1586.
9. Bassett A.S., Chow E.W., Husted J., Weksberg R., Caluseriu O., Webb G.D., et al. Clinical features of 78 adults with 22q11 deletion syndrome. Am. J. Med. Genet. A 2005, 138(4):307-313.
10. Bassett A.S., Caluseriu O., Weksberg R., Young D.A., Chow E.W. Catechol-O-methyl transferase and expression of schizophrenia in 73 adults with 22q11 deletion syndrome. Biol. Psychiatry 2007, 61(10):1135-1140.
11. Bergman A.J., Harvey P.D., Mitropoulou V., Aronson A., Marder D., Silverman J., et al. The factor structure of schizotypal symptoms in a clinical population. Schizophr. Bull. 1996, 22(3):501-509.
12. Cadenhead K.S., Swerdlow N.R., Shafer K.M., Diaz M., Braff D.L. Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits. Am. J. Psychiatry 2000, 157(10):1660-1668.
13. Statistical power analysis for the behavioral sciences (2nd ed.) 1988, Lawrence Erlbaum Associates, Publishers, Hillsdale, New Jersey. J. Cohen (Ed.).
14. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(12):6917-6922.
15. Endicott J., Spitzer R.L., Fleiss J.L., Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatry 1976, 33(6):766-771.
16. Fan J.B., Zhang C.S., Gu N.F., Li X.W., Sun W.W., Wang H.Y., et al. Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis. Biol. Psychiatry 2005, 57(2):139-144.
17. Fanous A.H., Neale M.C., Gardner C.O., Webb B.T., Straub R.E., O'Neill F.A., et al. Significant correlation in linkage signals from genome-wide scans of schizophrenia and schizotypy. Mol. Psychiatry 2007, 12(10):958-965.
18. Glatt S.J., Faraone S.V., Tsuang M.T. Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am. J. Psychiatry 2003, 160(3):469-476.
19. Gothelf D., Eliez S., Thompson T., Hinard C., Penniman L., Feinstein C., et al. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome. Nat. Neurosci. 2005, 8(11):1500-1502.
20. Grant P., Kuepper Y., Mueller E.A., Wielpuetz C., Mason O., Hennig J. Dopaminergic foundations of schizotypy as measured by the German version of the Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE)-a suitable endophenotype of schizophrenia. Front. Hum. Neurosci. 2013, 7:1.
21. Ikeda M., Williams N., Williams H.J., Smith R., Monks S., Owen M.J., et al. Failure to confirm association between PIK4CA and psychosis in 22q11.2 deletion syndrome. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B(4):980-982.
22. Karayiorgou M., Simon T.J., Gogos J.A. 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nat. Rev. Neurosci. 2010, 11(6):402-416.
23. Kendler K.S., McGuire M., Gruenberg A.M., O'Hare A., Spellman M., Walsh D. The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives. Arch. Gen. Psychiatry 1993, 50(7):527-540.
24. Liao S.Y., Lin S.H., Liu C.M., Hsieh M.H., Hwang T.J., Liu S.K., et al. Genetic variants in COMT and neurocognitive impairment in families of patients with schizophrenia. Genes Brain Behav. 2009, 8(2):228-237.
25. Malhotra A.K., Kestler L.J., Mazzanti C., Bates J.A., Goldberg T., Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am. J. Psychiatry 2002, 159(4):652-654.
26. Mason O., Claridge G. The Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE): further description and extended norms. Schizophr. Res. 2006, 82(2):203-211.
27. McDonald-McGinn D.M., Kirschner R., Goldmuntz E., Sullivan K., Eicher P., Gerdes M., et al. The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet. Couns. 1999, 10(1):11-24.
28. Munafo M.R., Bowes L., Clark T.G., Flint J. Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies. Mol. Psychiatry 2005, 10(8):765-770.
29. Murphy K.C. Schizophrenia and velo-cardio-facial syndrome. Lancet 2002, 359(9304):426-430.
30. Murphy K.C., Jones L.A., Owen M.J. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch. Gen. Psychiatry 1999, 56(10):940-945.
31. Nuechterlein K.H., Green M.F. MATRICS Consensus Cognitive Battery Manual 2006, MATRICS Assessment Inc., Los Angeles.
32. Pulver A.E., Nestadt G., Goldberg R., Shprintzen R.J., Lamacz M., Wolyniec P.S., et al. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J. Nerv. Ment. Dis. 1994, 182(8):476-478.
33. Rees E., Walters J.T.R., Chambert K.D., O'Dushlaine C., Szatkiewicz J., Richards A.L., et al. CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1. Hum. Mol. Genet. 2013, [in press].
34. Rees E., Walters J.T.R., Georgieva L., Isles A.R., Chambert K.D., Richards A.L., et al. Analysis of copy number variations at 15 schizophrenia-associated loci. Br. J. Psychiatry 2013, [in press].
35. Scambler P.J. The 22q11 deletion syndromes. Hum. Mol. Genet. 2000, 9(16):2421-2426.
36. Schneider M., Van der Linden M., Glaser B., Rizzi E., Dahoun S.P., Hinard C., et al. Preliminary structure and predictive value of attenuated negative symptoms in 22q11.2 deletion syndrome. Psychiatry Res. 2012, 196(2-3):277-284.
37. Shifman S., Bronstein M., Sternfeld M., Pisante-Shalom A., Lev-Lehman E., Weizman A., et al. A highly significant association between a COMT haplotype and schizophrenia. Am. J. Hum. Genet. 2002, 71(6).
38. Shprintzen R.J. Velo-cardio-facial syndrome: 30years of study. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review]. Dev. Disabil. Res. Rev. 2008, 14(1):3-10.
39. Siever L.J., Silverman J.M., Horvath T.B., Klar H., Coccaro E., Keefe R.S., et al. Increased morbid risk for schizophrenia-related disorders in relatives of schizotypal personality disordered patients. Arch. Gen. Psychiatry 1990, 47(7):634-640.
40. Vollema M.G., Hoijtink H. The multidimensionality of self-report schizotypy in a psychiatric population: an analysis using multidimensional Rasch models. Schizophr. Bull. 2000, 26(3):565-575.
41. Wechsler D. Wechsler Abbreviated Scale of Intelligence (WASI) Manual 1999, Psychological Corporation, San Antonio: TX.
42. Williams M. The Psychometric Assessment of Schizotypal Personality 1993, University of London, London.
43. Williams H.J., Owen M.J., O'Donovan M.C. Is COMT a susceptibility gene for schizophrenia?. Schizophr. Bull. 2007, 33(3):635-641.
44. Wing J.K., Babor T., Brugha T., Burke J., Cooper J.E., Giel R., et al. SCAN. Schedules for clinical assessment in neuropsychiatry. [Review]. Arch. Gen. Psychiatry 1990, 47(6):589-593.
45. Wing J.K., Babor T., Brugha T., Burke J., Cooper J.E., Giel R., et al. SCAN. Schedules for clinical assessment in neuropsychiatry. Arch. Gen. Psychiatry 1990, 47(6):589-593.